Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk
-
October 25, 2024
- Susan Krivelow HealthDay Reporter
A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.
Health News is provided as a service to Wickenburg Community Hospital Pharmacy site users by HealthDay. Wickenburg Community Hospital Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.
